Seasonal influenza vaccination: prioritizing children or other target groups?

Philippe Beutels, Yannick Vandendijck, Lander Willem, Nele Goeyvaerts, Adriaan Blommaert, Kim Van Kerckhove, Joke Bilcke, Germaine Hanquet, Pieter Neels, Nancy Thiry, Jori Liesenborgs, Niel HensOpenalex Unknown 2013 · DOI · OpenAlex

Introduction

Seasonal influenza remains a persistent challenge for healthcare systems worldwide. Traditionally, vaccination strategies have focused on "direct protection"—targeting individuals at the highest risk of severe complications, such as the elderly and those with chronic illnesses. However, a comprehensive report by the Belgian Health Care Knowledge Centre (KCE) explores a provocative alternative: shifting the focus toward "indirect protection" by vaccinating children, who are often the primary drivers of community transmission.

The Transmission Dilemma

Children are frequently described as the "engines" of influenza outbreaks. Due to high contact rates in schools and prolonged viral shedding, they spread the virus efficiently to other age groups. The KCE study investigated whether a universal childhood vaccination program in Belgium could generate sufficient herd immunity to protect the broader population more effectively and cost-efficiently than current methods.

The study weighs the benefits of vaccinating children to provide herd immunity versus direct protection for vulnerable adults.

Methodology: Modeling the Ripple Effect

To evaluate these strategies, researchers employed a sophisticated dual-modeling approach:

  1. Dynamic Transmission Model: An age-structured SEIRS (Susceptible-Exposed-Infectious-Recovered-Susceptible) model was developed to capture the "ripple effect" of vaccination. By using Belgian-specific social contact data (POLYMOD), the model could predict how vaccinating a child reduces the risk for their older relatives.
  2. Static Models: Standard decision-tree models were used for groups that do not significantly drive population-wide transmission, such as pregnant women, healthcare workers, and individuals with specific comorbidities.
  3. Economic Evaluation: The study calculated Incremental Cost-Effectiveness Ratios (ICERs) from a healthcare payer perspective, using 10,000 simulations to account for the inherent variability of flu seasons.

Key Insights: The Reality of Waning Immunity

One of the study's most significant findings involved the duration of vaccine-induced immunity. While some international models assume immunity lasts up to six years, the KCE model found that Belgian data best fit a scenario where immunity wanes rapidly, averaging just 1.68 years. This shorter window significantly reduces the long-term efficiency of childhood vaccination as a standalone strategy.

Furthermore, the study highlighted that administration costs are a decisive factor. If vaccines are administered individually by General Practitioners, the program's cost-effectiveness is poor (ICERs often above €40,000/QALY). However, if administration costs are reduced by 50-75% through school-based programs or well-baby clinics, the strategy becomes much more attractive, often falling below €30,000/QALY.

Strategic Results

  • No "Silver Bullet": The model demonstrated that childhood vaccination cannot replace adult vaccination. Even with 80% coverage among children, the elderly remain at significant risk. The most effective approach is always a combined strategy.
  • Vaccine Type: Live Attenuated Influenza Vaccine (LAIV), the nasal spray, generally outperformed the traditional TIV shot in children due to more stable efficacy across varying flu strains.
  • High-Risk Priorities: Vaccinating pregnant women and those with comorbidities remains a "best buy," with ICERs often below €10,000/QALY when integrated into routine medical visits.

Conclusion

The KCE report concludes that while vaccinating children offers clear benefits through herd immunity, it is not a panacea. For Belgium, the recommendation is to maintain the prioritization of high-risk groups and the elderly. A shift toward universal childhood vaccination should only be considered if administration can be streamlined—likely through school-based initiatives—to ensure economic viability.

Summary updated

BibTeX
@inproceedings{beutels2013seasonal,
  author = {Philippe Beutels and Yannick Vandendijck and Lander Willem and Nele Goeyvaerts and Adriaan Blommaert and Kim Van Kerckhove and Joke Bilcke and Germaine Hanquet and Pieter Neels and Nancy Thiry and Jori Liesenborgs and Niel Hens},
  title = {{Seasonal influenza vaccination: prioritizing children or other target groups?}},
  booktitle = {Openalex Unknown},
  year = {2013},
  doi = {10.57598/r204c},
}
Figure